Vergelijkende studie tussen PCEA en TAP-block als postoperatieve pijnstilling bij setio-patiënten

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-017326-39-BE

Enrollment

100

Registered

2009-12-08

Start date

2010-02-24

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain treatment after C-section

Interventions

Trade Name: chirocaïne Pharmaceutical Form: Injection* INN or Proposed INN: levobupivacaine CAS Number: 27262-48-2 Concentration unit: % percent Concentration type: equal Concentration number: 0.25-0.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: singleton pregnancy elective C-section women > 18 years of age Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: gestational age < 36 weeks allergy to study drug

Design outcomes

Primary

Measure	Time frame
Main Objective: To evaluate the quality of the post operative analgesia treatment. ;Secondary Objective: post operative mobility of the patient patient satisfaction duration of hospitalisation post operative urination problems;Primary end point(s):	—

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026